| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=10uM, 3-[({4-[4-({[1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid, Lysophospholipid edg2 (LPA1) Receptor Antagonists;LPAR1 antagonist;Lysophospholipid edg7 (LPA3) Receptor Antagonists;LPAR3 antagonist targeting LPAR1, LPAR3 (Novartis, 10367662) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/10367662 |
| Similar Terms | |
| Downloads & Tools |
1 genes differentially expressed following the BD-12-CM09_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| RPS5 | ribosomal protein S5 | 0.498215 |